OvaScience Inc (NASDAQ:OVAS)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as $0.90 and last traded at $0.90, with a volume of 484516 shares changing hands. The stock had previously closed at $0.95.
OVAS has been the topic of several research analyst reports. Zacks Investment Research raised shares of OvaScience from a “hold” rating to a “buy” rating and set a $1.25 target price on the stock in a research note on Wednesday, January 10th. HC Wainwright reissued a “buy” rating and set a $15.00 target price on shares of OvaScience in a research note on Friday, March 16th.
The company has a market cap of $33.94, a P/E ratio of -0.62 and a beta of 3.05.
A number of institutional investors have recently added to or reduced their stakes in OVAS. GMT Capital Corp acquired a new position in OvaScience during the 3rd quarter valued at about $1,138,000. Renaissance Technologies LLC increased its stake in OvaScience by 6,531.3% during the 4th quarter. Renaissance Technologies LLC now owns 782,165 shares of the biotechnology company’s stock valued at $1,095,000 after buying an additional 770,370 shares during the period. Deutsche Bank AG increased its stake in OvaScience by 7,476.4% during the 4th quarter. Deutsche Bank AG now owns 517,693 shares of the biotechnology company’s stock valued at $724,000 after buying an additional 510,860 shares during the period. Finally, Two Sigma Investments LP acquired a new position in OvaScience during the 4th quarter valued at about $342,000. 43.79% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “OvaScience (OVAS) Sets New 12-Month Low at $0.90” was published by Stock Observer and is the property of of Stock Observer. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.thestockobserver.com/2018/03/21/ovascience-ovas-sets-new-12-month-low-at-0-90.html.
OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.
Receive News & Ratings for OvaScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience and related companies with MarketBeat.com's FREE daily email newsletter.